Pancreatic Cancer Research

ResearcherBaylor College of MedicineActive in the last 2 years

Sheng Pan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0003-3500-9745; OpenAlex author ID A5006210822; NIH RePORTER profile ID 8843963. Sources: OpenAlex.

Their work

Papers
18 (first author 4, last author 4)
Trials
0
Grants
5
Labs led
2
Collaborators
29
Papers, trials and grants by year

2011: 1 paper · 2012: 2 papers, 1 grant · 2013: 2 papers · 2014: 1 paper, 1 grant · 2015: 2 papers · 2016: 1 paper · 2017: 3 papers · 2018: 1 grant · 2019: 1 paper · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 1 grant · 2025: none · 2026: 1 grant

Papers 18

  1. Protein Advanced Glycation End Products and Their Implications in Pancreatic Cancer. First author DOI 10.1158/1940-6207.capr-23-0162↗
  2. Increased neutrophil infiltration as a body-wide effect in pancreatic cancer development. First author DOI 10.1016/j.ebiom.2022.104089↗
  3. X-aptamers targeting Thy-1 membrane glycoprotein in pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.biochi.2020.11.018↗
  4. Proteome alterations in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2019.11.020↗
  5. Systemic Proteome Alterations Linked to Early Stage Pancreatic Cancer in Diabetic Patients. First author DOI 10.3390/cancers12061534↗
  6. Predictive proteomic signatures for response of pancreatic cancer patients receiving chemotherapy. Last author DOI 10.1186/s12014-019-9251-3↗
  7. Spectral library-based glycopeptide analysis-detection of circulating galectin-3 binding protein in pancreatic cancer. Last author DOI 10.1002/prca.201700064↗
  8. Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer. Last author DOI 10.1038/s41598-017-08436-6↗
  9. Long-lived pancreatic ductal adenocarcinoma slice cultures enable precise study of the immune microenvironment. Co-author DOI 10.1080/2162402x.2017.1333210↗
  10. Glycoproteins and glycoproteomics in pancreatic cancer. Co-author DOI 10.3748/wjg.v22.i42.9288↗
  11. Proteomics analysis of bodily fluids in pancreatic cancer. Co-author DOI 10.1002/pmic.201400476↗
  12. Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/labinvest.2014.128↗
  13. Quantitative glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma. Co-author DOI 10.1021/pr4010184↗
  14. Tissue proteomics in pancreatic cancer study: discovery, emerging technologies, and challenges. Co-author DOI 10.1002/pmic.201200319↗
  15. Unexpected gain of function for the scaffolding protein plectin due to mislocalization in pancreatic cancer. Co-author DOI 10.1073/pnas.1309720110↗
  16. Multiplex targeted proteomic assay for biomarker detection in plasma: a pancreatic cancer biomarker case study. Co-author DOI 10.1021/pr201117w↗
  17. Stromal galectin-1 expression is associated with long-term survival in resectable pancreatic ductal adenocarcinoma. First author DOI 10.4161/cbt.20842↗
  18. Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling. Co-author DOI 10.1021/pr101148r↗

Grants 5

  1. BLOOD-BASED PROTEOMIC ASSAY FOR PANCREATIC CANCER DETECTION UH3CA292130↗
  2. BLOOD-BASED PROTEOMIC ASSAY FOR PANCREATIC CANCER DETECTION UH2CA292130↗
  3. Early detection of pancreatic cancer in diabetics R01CA180949↗
  4. Quantitative glycoproteomics for pancreatic cancer studies K25CA137222↗
  5. Aberrant Glycosylation Signature in Pancreatic Cancer R21CA149772↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ru Chen · 17 shared papers, 3 shared grants, 2011–2026 · strength 4.29
  2. Teresa A. Brentnall · 15 shared papers, 1 shared grant, 2011–2021 · strength 1.27
  3. Lakmini Kumari Senavirathna · 1 shared paper, 2023 · strength 0.31
  4. Kimberly A. Kelly · 3 shared papers, 2013–2021 · strength 0.23
  5. Randall E. Brand · 3 shared papers, 2012–2020 · strength 0.22
  6. David W. Dawson · 2 shared papers, 2015–2021 · strength 0.18
  7. Eslam Nouri-Nigjeh · 2 shared papers, 2017 · strength 0.15
  8. Hongyu Wang · 1 shared paper, 2021 · strength 0.14
  9. Venu Gopal Pillarisetty · 2 shared papers, 2017 · strength 0.13
  10. Hong Peng · 1 shared paper, 2019 · strength 0.11
  11. Vincent J. Picozzi · 1 shared paper, 2019 · strength 0.11
  12. Yuanqing Yan · 1 shared paper, 2020 · strength 0.11
  13. Hong Peng · 1 shared paper, 2020 · strength 0.11
  14. Suresh T. Chari · 1 shared paper, 2020 · strength 0.11
  15. Gloria M. Petersen · 1 shared paper, 2020 · strength 0.11
  16. Roeland F. de Wilde · 2 shared papers, 2012–2015 · strength 0.07
  17. Niki A. Ottenhof · 2 shared papers, 2012–2015 · strength 0.07
  18. Anirban Maitra · 2 shared papers, 2012–2015 · strength 0.07
  19. Yongwoo David Seo · 1 shared paper, 2017 · strength 0.07
  20. Lei Wang · 1 shared paper, 2017 · strength 0.07
  21. Xiuyun Jiang · 1 shared paper, 2017 · strength 0.07
  22. Andrew L. Coveler · 1 shared paper, 2017 · strength 0.07
  23. Jae Hyuck Chang · 1 shared paper, 2017 · strength 0.07
  24. Meghna Waghray · 1 shared paper, 2015 · strength 0.04
  25. Christopher Lee Wolfgang · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.